✦ LIBER ✦

The role of dna repair processes in the response of human tumors to fractionated radiotherapy

✍ Scribed by Ralph R. Weichselbaum

Publisher: Elsevier Science
Year: 1984
Tongue: English
Weight: 910 KB
Volume: 10
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(84)90187-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor necrosis factor as an adjunct to f

Tumor necrosis factor as an adjunct to fractionated radiotherapy in the treatment of murine tumors

✍ Iku Nishiguchi; Veronica Willingham; Luka Milas 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 446 KB

Tumor volume, dose fractionation and rep

Tumor volume, dose fractionation and repopulation in the response of oral cavity and oropharynx cancers to radiotherapy

✍ B. Maciejewski; H.R. Withers; J.M.G. Taylor; A. Hliniak 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Role of H-2 antigens in the host respons

Role of H-2 antigens in the host response to methylcholanthrene-induced tumors

✍ Lars Ährlund-Richter; Eva Klein; Fernando Merino 📂 Article 📅 1982 🏛 Springer-Verlag 🌐 English ⚖ 526 KB

The role of DNA repair synthesis in chem

The role of DNA repair synthesis in chemical carcinogenesis and its relation to mutagenesis

✍ Alan Kolber 📂 Article 📅 1974 🏛 Springer-Verlag 🌐 English ⚖ 575 KB

Role of DNA repair in the mechanisms of

Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin

✍ P. Calsou; B. Salles 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 918 KB

Comparison of the effectiveness of tirap

Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation

✍ Amr El-Said; Douglas Menke; Mary Jo Dorie; J. Martin Brown 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

The goal of this study was to compare, with a human tumor xenograft, two different strategies for increasing tumor response to fractionated irradiation, namely, oxygenating the hypoxic tumor cells with carbogen and nicotinamide, or killing these cells with the hypoxic cytotoxin, tirapazamine (TPZ).